Medical professional sees spike in seasonal allergy patients yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
FMI, a leading market research and analysis firm, forecasts a significant upswing in the Global Allergy Immunotherapy Industry. In 2023, the market is set to reach an estimated value of US$ 1.74 billion, with a remarkable compound annual growth rate (CAGR) of 8.9% projected from 2023 to 2033. By 2033, the market is.
FMI’s projections indicate that the worldwide allergy immunotherapy market is on a trajectory to attain a valuation of approximately US$ 1.74 billion in 2023. Demonstrating robust growth at an impressive compound annual growth rate (CAGR) of 8.9% from 2023 to 2033, the market is expected to surpass the US$ 4.07 bill.